Effect of Hydralazine on Alzheimer's Disease

NCT04842552 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

424

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Hydralazine hydrochloride 25mg tablets
DRUG: Placebo

Sponsor

Shahid Sadoughi University of Medical Sciences and Health Services

Collaborators

[object Object]
[object Object]